176 related articles for article (PubMed ID: 38547725)
1. Copper homeostasis and cuproptosis in gynecological disorders: Pathogenic insights and therapeutic implications.
Lin Y; Yuan M; Wang G
J Trace Elem Med Biol; 2024 Jul; 84():127436. PubMed ID: 38547725
[TBL] [Abstract][Full Text] [Related]
2. Copper's dual role: unravelling the link between copper homeostasis, cuproptosis, and cardiovascular diseases.
Parsanathan R
Hypertens Res; 2024 May; 47(5):1440-1442. PubMed ID: 38467792
[TBL] [Abstract][Full Text] [Related]
3. Copper metabolism and cuproptosis in human malignancies: Unraveling the complex interplay for therapeutic insights.
Abdullah KM; Kaushal JB; Takkar S; Sharma G; Alsafwani ZW; Pothuraju R; Batra SK; Siddiqui JA
Heliyon; 2024 Mar; 10(5):e27496. PubMed ID: 38486750
[TBL] [Abstract][Full Text] [Related]
4. Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance.
Wang Y; Chen Y; Zhang J; Yang Y; Fleishman JS; Wang Y; Wang J; Chen J; Li Y; Wang H
Drug Resist Updat; 2024 Jan; 72():101018. PubMed ID: 37979442
[TBL] [Abstract][Full Text] [Related]
5. Elucidating cuproptosis in metabolic dysfunction-associated steatotic liver disease.
Li Y; Qi P; Song SY; Wang Y; Wang H; Cao P; Liu Y; Wang Y
Biomed Pharmacother; 2024 May; 174():116585. PubMed ID: 38615611
[TBL] [Abstract][Full Text] [Related]
6. Roles and mechanisms of copper homeostasis and cuproptosis in osteoarticular diseases.
Han J; Luo J; Wang C; Kapilevich L; Zhang XA
Biomed Pharmacother; 2024 May; 174():116570. PubMed ID: 38599063
[TBL] [Abstract][Full Text] [Related]
7. Exploring cuproptosis as a mechanism and potential intervention target in cardiovascular diseases.
Yang Y; Feng Q; Luan Y; Liu H; Jiao Y; Hao H; Yu B; Luan Y; Ren K
Front Pharmacol; 2023; 14():1229297. PubMed ID: 37637426
[TBL] [Abstract][Full Text] [Related]
8. Cuproptosis: Unraveling the Mechanisms of Copper-Induced Cell Death and Its Implication in Cancer Therapy.
Springer C; Humayun D; Skouta R
Cancers (Basel); 2024 Feb; 16(3):. PubMed ID: 38339398
[TBL] [Abstract][Full Text] [Related]
9. Copper Metabolism and Cuproptosis: Molecular Mechanisms and Therapeutic Perspectives in Neurodegenerative Diseases.
Ban XX; Wan H; Wan XX; Tan YT; Hu XM; Ban HX; Chen XY; Huang K; Zhang Q; Xiong K
Curr Med Sci; 2024 Feb; 44(1):28-50. PubMed ID: 38336987
[TBL] [Abstract][Full Text] [Related]
10. Cuproptosis: unveiling a new frontier in cancer biology and therapeutics.
Feng Y; Yang Z; Wang J; Zhao H
Cell Commun Signal; 2024 May; 22(1):249. PubMed ID: 38693584
[TBL] [Abstract][Full Text] [Related]
11. Copper homeostasis and cuproptosis in mitochondria.
Tian Z; Jiang S; Zhou J; Zhang W
Life Sci; 2023 Dec; 334():122223. PubMed ID: 38084674
[TBL] [Abstract][Full Text] [Related]
12. Copper homeostasis and cuproptosis in tumor pathogenesis and therapeutic strategies.
Bian C; Zheng Z; Su J; Chang S; Yu H; Bao J; Xin Y; Jiang X
Front Pharmacol; 2023; 14():1271613. PubMed ID: 37767404
[TBL] [Abstract][Full Text] [Related]
13. Regulatory roles of copper metabolism and cuproptosis in human cancers.
Wang Z; Jin D; Zhou S; Dong N; Ji Y; An P; Wang J; Luo Y; Luo J
Front Oncol; 2023; 13():1123420. PubMed ID: 37035162
[TBL] [Abstract][Full Text] [Related]
14. Cuproptosis and cuproptosis-related genes: Emerging potential therapeutic targets in breast cancer.
Liu X; Luo B; Wu X; Tang Z
Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):189013. PubMed ID: 37918452
[TBL] [Abstract][Full Text] [Related]
15. Cuproptosis: Mechanism, role, and advances in urological malignancies.
Wu J; He J; Liu Z; Zhu X; Li Z; Chen A; Lu J
Med Res Rev; 2024 Jul; 44(4):1662-1682. PubMed ID: 38299968
[TBL] [Abstract][Full Text] [Related]
16. Copper homeostasis and cuproptosis in health and disease.
Chen L; Min J; Wang F
Signal Transduct Target Ther; 2022 Nov; 7(1):378. PubMed ID: 36414625
[TBL] [Abstract][Full Text] [Related]
17. Copper homeostasis and cuproptosis in atherosclerosis: metabolism, mechanisms and potential therapeutic strategies.
Yang S; Li Y; Zhou L; Wang X; Liu L; Wu M
Cell Death Discov; 2024 Jan; 10(1):25. PubMed ID: 38218941
[TBL] [Abstract][Full Text] [Related]
18. Copper homeostasis and cuproptosis in cardiovascular disease therapeutics.
Yang L; Yang P; Lip GYH; Ren J
Trends Pharmacol Sci; 2023 Sep; 44(9):573-585. PubMed ID: 37500296
[TBL] [Abstract][Full Text] [Related]
19. Cope with copper: From molecular mechanisms of cuproptosis to copper-related kidney diseases.
Zou Y; Wu S; Xu X; Tan X; Yang S; Chen T; Zhang J; Li S; Li W; Wang F
Int Immunopharmacol; 2024 May; 133():112075. PubMed ID: 38663316
[TBL] [Abstract][Full Text] [Related]
20. Emerging insights into cuproptosis and copper metabolism: implications for age-related diseases and potential therapeutic strategies.
Fan H; Wang K; Zhao X; Song B; Yao T; Liu T; Gao G; Lu W; Liu C
Front Aging Neurosci; 2024; 16():1335122. PubMed ID: 38715962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
